2770.3000 -81.50 (-2.86%)
NSE Sep 05, 2025 15:31 PM
Volume: 64,535
 

2770.30
-2.86%
Karvy
Revenue growth on account of low base due to GST: Revenues for the quarter at Rs 7357 mn were above our estimates of Rs 6675mn on account of low base due to GST last year. The operatingmargins at 19.1% in Q1FY19 were in line with our estimates of 19%.
GlaxoSmithKline Pharmaceuticals Ltd. is trading above its 200 day SMA of 2708.3
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended